Macrophage-derived IL1B and TNFa regulate arginine metabolism in neuroblastoma

Livingstone Fultang, Laura D. Gamble, Luciana Gneo, Andrea M. Berry, Sharon A. Egan, Fenna De Bie, Orli Yogev, Georgina Eden, Sarah Booth, Samantha Brownhill, Ashley Vardon, Carmel M. McConville, Paul N. Cheng, Murray D. Norris, Heather C. Etchevers, Jayne Murray, David S. Ziegler, Louis Chesler, Ronny Schmidt, Susan A. Burchill & 3 others Michelle Haber, Carmela De Santo, Francis Mussai

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Neuroblastoma is the most common childhood solid tumor, yet the prognosis for high-risk disease remains poor. We demonstrate here that arginase 2 (ARG2) drives neuroblastoma cell proliferation via regulation of arginine metabolism. Targeting arginine metabolism, either by blocking cationic amino acid transporter 1 (CAT-1)-dependent arginine uptake in vitro or therapeutic depletion of arginine by pegylated recombinant arginase BCT-100, significantly delayed tumor development and prolonged murine survival. Tumor cells polarized infiltrating monocytes to an M1-macrophage phenotype, which released IL1b and TNFa in a RAC-alpha serine/threonine-protein kinase (AKT)-dependent manner. IL1b and TNFa established a feedback loop to upregulate ARG2 expression via p38 and extracellular regulated kinases 1/2 (ERK1/2) signaling in neuroblastoma and neural crest-derived cells. Proteomic analysis revealed that enrichment of IL1b and TNFa in stage IV human tumor microenvironments was associated with a worse prognosis. These data thus describe an immune-metabolic regulatory loop between tumor cells and infiltrating myeloid cells regulating ARG2, which can be clinically exploited.

LanguageEnglish
Pages611-624
Number of pages14
JournalCancer Research
Volume79
Issue number3
DOIs
Publication statusPublished - 1 Jan 2019

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Fultang, L., Gamble, L. D., Gneo, L., Berry, A. M., Egan, S. A., De Bie, F., ... Mussai, F. (2019). Macrophage-derived IL1B and TNFa regulate arginine metabolism in neuroblastoma. Cancer Research, 79(3), 611-624. https://doi.org/10.1158/0008-5472.CAN-18-2139
Fultang, Livingstone ; Gamble, Laura D. ; Gneo, Luciana ; Berry, Andrea M. ; Egan, Sharon A. ; De Bie, Fenna ; Yogev, Orli ; Eden, Georgina ; Booth, Sarah ; Brownhill, Samantha ; Vardon, Ashley ; McConville, Carmel M. ; Cheng, Paul N. ; Norris, Murray D. ; Etchevers, Heather C. ; Murray, Jayne ; Ziegler, David S. ; Chesler, Louis ; Schmidt, Ronny ; Burchill, Susan A. ; Haber, Michelle ; De Santo, Carmela ; Mussai, Francis. / Macrophage-derived IL1B and TNFa regulate arginine metabolism in neuroblastoma. In: Cancer Research. 2019 ; Vol. 79, No. 3. pp. 611-624.
@article{6802f8e383984b79a78423d5822dd095,
title = "Macrophage-derived IL1B and TNFa regulate arginine metabolism in neuroblastoma",
abstract = "Neuroblastoma is the most common childhood solid tumor, yet the prognosis for high-risk disease remains poor. We demonstrate here that arginase 2 (ARG2) drives neuroblastoma cell proliferation via regulation of arginine metabolism. Targeting arginine metabolism, either by blocking cationic amino acid transporter 1 (CAT-1)-dependent arginine uptake in vitro or therapeutic depletion of arginine by pegylated recombinant arginase BCT-100, significantly delayed tumor development and prolonged murine survival. Tumor cells polarized infiltrating monocytes to an M1-macrophage phenotype, which released IL1b and TNFa in a RAC-alpha serine/threonine-protein kinase (AKT)-dependent manner. IL1b and TNFa established a feedback loop to upregulate ARG2 expression via p38 and extracellular regulated kinases 1/2 (ERK1/2) signaling in neuroblastoma and neural crest-derived cells. Proteomic analysis revealed that enrichment of IL1b and TNFa in stage IV human tumor microenvironments was associated with a worse prognosis. These data thus describe an immune-metabolic regulatory loop between tumor cells and infiltrating myeloid cells regulating ARG2, which can be clinically exploited.",
author = "Livingstone Fultang and Gamble, {Laura D.} and Luciana Gneo and Berry, {Andrea M.} and Egan, {Sharon A.} and {De Bie}, Fenna and Orli Yogev and Georgina Eden and Sarah Booth and Samantha Brownhill and Ashley Vardon and McConville, {Carmel M.} and Cheng, {Paul N.} and Norris, {Murray D.} and Etchevers, {Heather C.} and Jayne Murray and Ziegler, {David S.} and Louis Chesler and Ronny Schmidt and Burchill, {Susan A.} and Michelle Haber and {De Santo}, Carmela and Francis Mussai",
year = "2019",
month = "1",
day = "1",
doi = "10.1158/0008-5472.CAN-18-2139",
language = "English",
volume = "79",
pages = "611--624",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

Fultang, L, Gamble, LD, Gneo, L, Berry, AM, Egan, SA, De Bie, F, Yogev, O, Eden, G, Booth, S, Brownhill, S, Vardon, A, McConville, CM, Cheng, PN, Norris, MD, Etchevers, HC, Murray, J, Ziegler, DS, Chesler, L, Schmidt, R, Burchill, SA, Haber, M, De Santo, C & Mussai, F 2019, 'Macrophage-derived IL1B and TNFa regulate arginine metabolism in neuroblastoma', Cancer Research, vol. 79, no. 3, pp. 611-624. https://doi.org/10.1158/0008-5472.CAN-18-2139

Macrophage-derived IL1B and TNFa regulate arginine metabolism in neuroblastoma. / Fultang, Livingstone; Gamble, Laura D.; Gneo, Luciana; Berry, Andrea M.; Egan, Sharon A.; De Bie, Fenna; Yogev, Orli; Eden, Georgina; Booth, Sarah; Brownhill, Samantha; Vardon, Ashley; McConville, Carmel M.; Cheng, Paul N.; Norris, Murray D.; Etchevers, Heather C.; Murray, Jayne; Ziegler, David S.; Chesler, Louis; Schmidt, Ronny; Burchill, Susan A.; Haber, Michelle; De Santo, Carmela; Mussai, Francis.

In: Cancer Research, Vol. 79, No. 3, 01.01.2019, p. 611-624.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Macrophage-derived IL1B and TNFa regulate arginine metabolism in neuroblastoma

AU - Fultang, Livingstone

AU - Gamble, Laura D.

AU - Gneo, Luciana

AU - Berry, Andrea M.

AU - Egan, Sharon A.

AU - De Bie, Fenna

AU - Yogev, Orli

AU - Eden, Georgina

AU - Booth, Sarah

AU - Brownhill, Samantha

AU - Vardon, Ashley

AU - McConville, Carmel M.

AU - Cheng, Paul N.

AU - Norris, Murray D.

AU - Etchevers, Heather C.

AU - Murray, Jayne

AU - Ziegler, David S.

AU - Chesler, Louis

AU - Schmidt, Ronny

AU - Burchill, Susan A.

AU - Haber, Michelle

AU - De Santo, Carmela

AU - Mussai, Francis

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Neuroblastoma is the most common childhood solid tumor, yet the prognosis for high-risk disease remains poor. We demonstrate here that arginase 2 (ARG2) drives neuroblastoma cell proliferation via regulation of arginine metabolism. Targeting arginine metabolism, either by blocking cationic amino acid transporter 1 (CAT-1)-dependent arginine uptake in vitro or therapeutic depletion of arginine by pegylated recombinant arginase BCT-100, significantly delayed tumor development and prolonged murine survival. Tumor cells polarized infiltrating monocytes to an M1-macrophage phenotype, which released IL1b and TNFa in a RAC-alpha serine/threonine-protein kinase (AKT)-dependent manner. IL1b and TNFa established a feedback loop to upregulate ARG2 expression via p38 and extracellular regulated kinases 1/2 (ERK1/2) signaling in neuroblastoma and neural crest-derived cells. Proteomic analysis revealed that enrichment of IL1b and TNFa in stage IV human tumor microenvironments was associated with a worse prognosis. These data thus describe an immune-metabolic regulatory loop between tumor cells and infiltrating myeloid cells regulating ARG2, which can be clinically exploited.

AB - Neuroblastoma is the most common childhood solid tumor, yet the prognosis for high-risk disease remains poor. We demonstrate here that arginase 2 (ARG2) drives neuroblastoma cell proliferation via regulation of arginine metabolism. Targeting arginine metabolism, either by blocking cationic amino acid transporter 1 (CAT-1)-dependent arginine uptake in vitro or therapeutic depletion of arginine by pegylated recombinant arginase BCT-100, significantly delayed tumor development and prolonged murine survival. Tumor cells polarized infiltrating monocytes to an M1-macrophage phenotype, which released IL1b and TNFa in a RAC-alpha serine/threonine-protein kinase (AKT)-dependent manner. IL1b and TNFa established a feedback loop to upregulate ARG2 expression via p38 and extracellular regulated kinases 1/2 (ERK1/2) signaling in neuroblastoma and neural crest-derived cells. Proteomic analysis revealed that enrichment of IL1b and TNFa in stage IV human tumor microenvironments was associated with a worse prognosis. These data thus describe an immune-metabolic regulatory loop between tumor cells and infiltrating myeloid cells regulating ARG2, which can be clinically exploited.

UR - http://www.scopus.com/inward/record.url?scp=85060936151&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-18-2139

DO - 10.1158/0008-5472.CAN-18-2139

M3 - Article

VL - 79

SP - 611

EP - 624

JO - Cancer Research

T2 - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 3

ER -

Fultang L, Gamble LD, Gneo L, Berry AM, Egan SA, De Bie F et al. Macrophage-derived IL1B and TNFa regulate arginine metabolism in neuroblastoma. Cancer Research. 2019 Jan 1;79(3):611-624. https://doi.org/10.1158/0008-5472.CAN-18-2139